Publications

5803 Results

Evaluation of which patients get a second course of 3+7 on cooperative group trials for newly diagnosed acute myeloid leukemia: a report from SWOG

Authors
M Othus;F Appelbaum;S Petersdorf;HP Erba;E Estey
Journal / Conference
Blood 122:3925; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106

Prediction of CR on reinduction in patients with newly diagnosed acute myeloid leukemia given intensive induction regimens: a report from SWOG and Cleveland Clinic

Authors
M Othus;S Mukherjee;MA Sekeres;J Godwin;J Anderson;S Petersdorf;F Appelbaum;HP Erba;E Estey
Journal / Conference
Blood 122:2686; American Society of Hematology meeting (Dec 7-10, 2013, New Orleans, LA), poster presentation;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9333

Frontline treatment of acute lymphoblastic leukemia (ALL) in older adolescents and young adults (AYA) using a pediatric regimen is feasible: toxicity results of the prospective US intergroup trial CALGB 10403 (Alliance)

Authors
A Advani;B Sanford;S Luger;M Devidas;E Larsen;M Liedtke;p Voorhees;M Foster;D Claxton;E Parker;K Coffan;W Carroll;N Winik;S Coutre;M Tallman;F Appelbaum;H Erba;R Stone;S Hunger;RA Larson;W Stock
Journal / Conference
Blood 122:1443; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
C10403

Improved risk stratification with addition of male sex (S) to the elderly international prognostic index (S-EIPI) for DLBCL patients > 60 years treated with R-CHOP: an international collaboration of the US intergoup, German high-grade non-hodgkin lymphoma study group and groupe d'etude de lymphome d'adultes

Authors
RH Advani;F Hong;TM Habermann;H Li;B Kahl;VA Morrison;EA Weller;G Varma;RI Fisher;BA Peterson;BD Cheson;R Gascoyne;SJ Horning;S Bousetta;B Coiffier;M Ziepert;M Pfreundschuh
Journal / Conference
Blood 122:3045; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orlean, LA), poster;
Year
2013
Research Committee(s)
Lymphoma
Study Number(s)
E4494

Prediction of therapeutic resistance in adult acute myeloid leukemia: analysis of 4,550 newly diagnosed patients from MRC/NCRI, HOVON, SWOG, and MD Anderson Cancer Center

Authors
R Walter;M Othus;AK Burnett;AK Burnett;B Lowenberg;H Kantarjian;GJ Ossenkoppele;RK Hills;F Ravandi;A Evans;SA Pierce;F Appelbaum;E Estey
Journal / Conference
Blood 122:64; American Society of Hematology annual meeting (Dec 7-10, 2013), oral;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9333, SWOG-9500, S9617, S9918

The addition of gemtuzumab ozogamicin (GO) to induction chemotherapy reduces relapse and improves survival in patients without adverse risk karyotype: results of an individual patient meta-analysis of the five randomised trials

Authors
R Hills;S Petersdorf;E Estey;M Othus;F Appelbaum;S Castaigne;H Dombret;S Chevert;J Delaunay;N Ifrah;J-Y Chan;C Recher;AK Burnett
Journal / Conference
Blood 122:356, 2013; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), oral;
Year
2013
Research Committee(s)
Leukemia
PMID
n/a
PMC
n/a
Study Number(s)
S0106

The role of body mass index in survival outcome for lymphoma patients: an Eastern Cooperative Oncology Group Experience

Authors
F Hong;TM Habermann;LI Gordon;H Hochster;R Gascoyne;RI Fisher;N Bartlett;P Stiff;B Cheson;M Crump;S Horning;B Kahl
Journal / Conference
Blood 122:3060; American Society of Hematology annual meeting (Dec 7-10, 2013), poster;
Year
2013
Research Committee(s)
Lymphoma
Study Number(s)
E2496, E4494

Alteration of cytogenetic risk stratification in new diagnosis of leukemia by FISH testing - the SWOG experience

Authors
M Fang;S McDonough;M Othus;L Zhuo;D Roulston;H Erba;F Appelbaum
Journal / Conference
Blood 122:1383; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106, S0112, S0301, S0325, S0333, S0432, S0521, S0530, S0535, S0605, S0703

Impact of cytarabine dose in the induction regimen on the outcome of patients with newly diagnosed acute myeloid leukemia with or without NPM1 and/or FLT3 mutations: A SWOG and MD Anderson Cancer Center Report

Authors
M Othus;F Ravandi;S Faderl;D Stirewalt;S Pierce;G Borthakur;J Godwin;J Anderson;S Petersdorf;J Cortes;F Ostronoff;E Pogosova-Agadijanyan;F Appelbaum;H Kantarjian;E Estey
Journal / Conference
Blood 122:2686; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106, SWOG-9031, SWOG-9333, SWOG-9500

NUP98/NSD1 translocation further risk-stratifies patients with FLT3/ITD in acute myeloid leukemia: A report from Children’s Oncology Group and SWOG

Authors
F Ostronoff;M Othus;RB Gerbing;MR Loken;S Raimondi;B Hirsch;BJ Lange;S Petersdorf;J Radich;F Appelbaum;AS Gamis;TA Alonzo;S Meshinchi
Journal / Conference
Blood 122:488; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), oral;
Year
2013
Research Committee(s)
Leukemia
Study Number(s)
S0106